Loading insider details...
Beta
Latest Form 4 (Apr 20, 2026): Sale of 36,500 MIST shares, $82.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 20, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Sale | 36,500 | $82.5K |
| Feb 4, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 679,000 | n/a |
| Jan 28, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 280,000 | n/a |
| Jan 9, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Sale | 500 | $1.1K |
| Jul 15, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 66,666 | n/a |
| Jan 29, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 399,600 | n/a |
| Feb 17, 2023 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 360,000 | n/a |
| Mar 24, 2022 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 500,000 | n/a |
| Mar 27, 2021 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 670,000 | n/a |
| Jun 8, 2020 | Milestone Pharmaceuticals Inc. (MIST) | Exercise/Conversion | 7,400 | $11.4K |